<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211221053479N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-01-02</date_registration>
      <primary_sponsor>University of Lahore</primary_sponsor>
      <public_title>Vestibular stimulation's effect on balance and motor function in cerebral palsy patients</public_title>
      <acronym></acronym>
      <scientific_title>Effects of vestibular  stimulation on motor function  and balance in children with  hypotonic cerebral palsy : A  Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>68</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60797</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Purposive Random Sampling technique will be carried out. For this purpose, Computer generated randomization method will be used to allocate our participants in 2 groups. Total 68 numbers will be added and the software will randomly allocate the numbers into either group A or Group B. These numbers will be given to Athetoid Cerebral palsy patient's care giver who will come to the outpatient department of physical therapy. The numbers will be assigned according to their visit i.e.those who will come first will be given 1 number in such a way as if for example the software has allocated 1 into group B, he will receive the treatment designed for group B and who will come at 10th number Will be given 10th number concealed envelope and so forth. The concealed envelope will be used for this purpose. Allocation concealment will be done by sequential numbering of patients, Blinding description: The study will be double blinded and care giver and outcome assessor will be unaware of treatment given to patients. Both the outcome assessor and caregiver will not be explained about treatment given to patient.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hypotonic cerebral palsy.</hc_freetext>
      <i_freetext>Intervention 1: Control group: will receive conventional physical therapy for hypotonic cerebral palsy. For conventional physiotherapy group, the training duration for each session will be 30 minutes with 5 minutes of rest period. Participants in group A will be given Conventional Physiotherapy. It includes Passive Soft tissue elongation of tight muscles, Lower limb resistance exercises, Movement transitions, balance board and foam board standing, walking and stair climbing. Intervention 2: Intervention group: will receive vestibular stimulation along with the routine physical therapy and for intervention group,the session will last 30 minutes with 10 minutes of rest period in between. Along with conventional physical therapy vestibular stimulation wi be given and will include exercises such as Swinging in standing in all directions, trampoline jumps, rocking movement in rocking chair,gaze stabilization exercises and visual pursuit exercises under supervision.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The title of our study is"EFFECTS OF VESTIBULAR STIMULATION ON MOTOR FUNCTION AND BALANCE IN CHILDREN WITH HYPOTONIC CEREBRAL PALSY: A RANDOMIZED CONTROLLED TRIAL". All collected deidentified IPD will be shared

When:
Data will become available from 12_06_2022 to 12_07_2023

To whom:
Those involved in research related to Cerebral Palsy's Interventions

Conditions:
For citation purposes only.

Where to obtain:
Data will be obtained from Principal investigator via email using the email address zulfiqar1991khan@gmail.com

How to obtain:
Data can be accessed Upon request to principal investigator via Email. And the mailing address is zulfiqar1991khan@gmail.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahwash Zulfiqar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>118 /3A Judicial Colony Phase 2, Lahore</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>537000</zip>
        <telephone>+92 335 5077906</telephone>
        <email>Zulfiqar1991khan@gmail.com</email>
        <affiliation>University of Lahore</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahwash Zulfiqar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>118 /3A judicial colony phase 2, Lahore</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>537000</zip>
        <telephone>+92 335 5077906</telephone>
        <email>Zulfiqar1991khan@gmail.com</email>
        <affiliation>University of Lahore</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Children of age between 5-10 year will be included in our study
Patients who will have good head control will be included
Children with Hypotonic cerebral palsy will be included in our study
Children who will be able to maintain ring sitting position will be included</inclusion_criteria>
      <agemin>5 years</agemin>
      <agemax>10 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Children who will not respond to Visual and auditory stimuli due to blindness or deafness or severe mental retardation
Children with uncontrolled convulsion or any kind of shunt
Children with severe medical problems
Children with orthopedic condition.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G80</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cerebral palsy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: will receive conventional physical therapy for hypotonic cerebral palsy. For conventional physiotherapy group, the training duration for each session will be 30 minutes with 5 minutes of rest period. Participants in group A will be given Conventional Physiotherapy. It includes Passive Soft tissue elongation of tight muscles, Lower limb resistance exercises, Movement transitions, balance board and foam board standing, walking and stair climbing</i_keyword>
      <i_keyword>Intervention group: will receive vestibular stimulation along with the routine physical therapy and for intervention group,the session will last 30 minutes with 10 minutes of rest period in between. Along with conventional physical therapy vestibular stimulation wi be given and will include exercises such as Swinging in standing in all directions, trampoline jumps, rocking movement in rocking chair,gaze stabilization exercises and visual pursuit exercises under supervision</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Balance. Timepoint: Balance will be assessed at baseline, 1st, 3rd and 5th week post intervention. Method of measurement: Balance will be assessed using pediatric balance scale.</prim_outcome>
      <prim_outcome>Gross motor function. Timepoint: Gross motor function will be assessed using gross motor function scale at baseline, 1st,3rd and 5th week post intervention. Method of measurement: Gross motor function will be assessed using gross motor function scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of Lahore</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-07-01</approval_date>
        <contact_name>Ethics committee of University of Lahore</contact_name>
        <contact_address>1km.off defence road, Lahore Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
